- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-19-0024332

About S.G.Biopharm Private Limited
Data last updated:
S.G.Biopharm Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 August 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24299MH2018PTC312547. Its GSTIN is 27ABACS6549N1ZP (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Anand Ganpatbhai Trivedi and Niraj Harshad Dholakiya.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A/502 Narmada Enclave Chs Ltd. Shimpoli Off S.V.Road Borivali West, Mumbai, Maharashtra, India – 400092.
As per the financials filed for FY 2025, the company reported a revenue of ₹45.39 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹44.13 Lakh (net margin 1%) and EBITDA of ₹4.87 Cr (EBITDA margin 10.7%). Revenue has grown at a compounded annual rate (CAGR) of 55% over three years and 26% over five years.
Its group structure includes 1 subsidiary.
The company is associated with 1 brand: SG Biopharm. As per MCA filings, the company has open charges of ₹19.8 Cr and satisfied charges of ₹9.56 Cr on record.
S.G.Biopharm Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0024332). For more details, the company can be reached via its website sgbiopharm.com.
Company details
Recognitions & Rankings of S.G.Biopharm
Contact details
S.G.Biopharm Private Limited's registered office is in Mumbai, Maharashtra. Its website is sgbiopharm.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressA/502 Narmada Enclave Chs Ltd. Shimpoli Off S.V.Road Borivali West, Mumbai, Maharashtra, India – 400092
- IndustryPharma, Drug Formulation & Development
To see the full contact details of S.G.Biopharm Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
S.G.Biopharm operates one associated brand: SG Biopharm. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing and exporting of formulations and biopharmaceuticals in the healthcare sector. | sgbiopharm.com |
Business activity
The main business activity of S.G.Biopharm is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of S.G.Biopharm Private Limited, buy the company report.
Financials of S.G.Biopharm Private Limited
FY 2025 filings availableS.G.Biopharm Private Limited reported revenue of ₹45.39 Cr (up 10% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 26% over five years, including 10% growth in the latest year. EBITDA rose 61% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.87 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹44.13 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.7% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of S.G.Biopharm Private Limited, buy the company report.
Board of directors of S.G.Biopharm Private Limited
S.G.Biopharm has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anand Ganpatbhai Trivedi Also directs: Ambix Healthcare LLP, Welvita Healthcare Private Limited, Sunders Kitchen Private Limited and 1 more | Director | 07 Aug 2018 | 8 Years 2 Months | Current |
| Niraj Harshad Dholakiya Also directs: Swanira Lifesciences Private Limited | Director | 19 Jul 2019 | 7 Years 3 Months | Current |
| Amitkumar Ganpatbhai Trivedi Also directs: Ambix Healthcare LLP, Pharmachem Biotech (I) Private Limited, Padmanabh Dal Mill LLP and 1 more | Director | 07 Aug 2018 | 8 Years 2 Months | Current |
Auditor
S.G.Biopharm Private Limited is audited by S N & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S N & CO. | FY 2023 | 128887W |
Shareholding
The shareholding of S.G.Biopharm Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of S.G.Biopharm Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 19 Nov 2024 | 101002812 | Others | ₹4 Cr | Open | |
| 24 Apr 2024 | 100913635 | Others | ₹5.4 Cr | Open | |
| 04 Sep 2023 | 100777557 | Sidbi | ₹69.51 Lakh | Open | |
| 06 Jun 2023 | 100727755 | Others | ₹9.71 Cr | Open | |
| 24 Feb 2023 | 100691155 | Others | ₹3.15 Cr | Satisfied |
To see the full charge records of S.G.Biopharm Private Limited, buy the company report.
Total charge records: 8 View all charges
Legal cases
No court or tribunal cases involving S.G.Biopharm Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
S.G.Biopharm Private Limited has 15 MSME Form 1 returns on record between 2019 and 2024, listing 210 overdue payments to 42 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 42)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Rich Prints Private Limited | |||
| Shah Print & Pack | |||
| Sri Ramchandra Shipping Agencies Private Limited | |||
| Invochem Laboratory | |||
| Sarthi Pharma CR |
To see the full MSME payment records of S.G.Biopharm Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
S.G.Biopharm has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Vetenza Animal Healthcare Private Limited | U24231MH2020PTC337304 |
To see the full group structure of S.G.Biopharm Private Limited, buy the company report.
GST
S.G.Biopharm has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27ABACS6549N1ZP | Maharashtra | Active | 22 Feb 2022 |
| 24ABACS6549N1ZV | Gujarat | Active | 27 Sep 2018 |
To see the full GST registrations and return filing status of S.G.Biopharm Private Limited, buy the company report.
Recent activity
S.G.Biopharm Private Limited has 4 board changes on record since 2018: 3 appointments and 1 cessation. The latest: Niraj Harshad Dholakiya ceased to be Additional Director on 19 Oct 2019.
8 earlier events are in the company report.
Frequently asked questions
S.G.Biopharm is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 August 2018 (8+ years old) and is registered under CIN U24299MH2018PTC312547.
S.G.Biopharm has 3 current directors:
- Anand Ganpatbhai Trivedi - Director
- Niraj Harshad Dholakiya - Director
- Amitkumar Ganpatbhai Trivedi - Director
The latest financial statements of S.G.Biopharm on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of S.G.Biopharm is 27ABACS6549N1ZP, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 24ABACS6549N1ZV (Gujarat).
The CIN (Corporate Identification Number) of S.G.Biopharm is U24299MH2018PTC312547. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
S.G.Biopharm was incorporated on 07 August 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
Niraj Harshad Dholakiya ceased to be Additional Director on 19 Oct 2019. Niraj Harshad Dholakiya was appointed as Director on 19 Jul 2019. Amitkumar Ganpatbhai Trivedi was appointed as Director on 07 Aug 2018. S.G.Biopharm has 4 board changes on record in total.
Yes, S.G.Biopharm is registered as a small enterprise under Udyam registration (number: UDYAM-MH-19-0024332).
S.G.Biopharm has 15 MSME Form 1 returns on record between 2019 and 2024, listing 210 overdue payments to 42 micro and small suppliers. The latest return was filed on 26 Apr 2024.
S.G.Biopharm can be reached through the website sgbiopharm.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of S.G.Biopharm is at A502 Narmada Enclave Chs Ltd. Shimpoli Off S.V.Road Borivali West, Mumbai, Maharashtra, India – 400092.

